Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury

Chem Biol Interact. 2024 Jan 5:387:110825. doi: 10.1016/j.cbi.2023.110825. Epub 2023 Dec 5.

Abstract

Given that the severity of the chemotherapy-induced ovarian damage, effective fertility preservation is a necessary part of the treatment process. Ferroptosis is a regulated cell death triggered by excessive phospholipid peroxidation caused by iron and the role of ferroptosis in chemotherapy-induced ovarian damage remains unclear. In this study, we demonstrated that cisplatin treatment caused the accumulation of iron ions which induced ferroptosis in ovarian tissue. And our results show that ferrostatin-1 was able to suppress the ovarian injury and granulosa cell death caused by cisplatin (Cis) in vivo and in vitro. At the same time, we observed significant changes in the expression levels of Acyl-CoA synthetase long-chain family member 4 (Acsl4) and glutathione peroxidase 4 (GPX4). Similarly, Rosiglitazone, an inhibitor of Acsl4, administration alleviated the ovary damage of the mice undergoing chemotherapy. Further mechanistic investigation showed that cisplatin increased the expression level of specificity protein 1 (SP1), and SP1 could bind to the promoter of Acsl4 to increased Acsl4 transcription. Overall, ferroptosis plays an important role in Cis induced ovarian injury, and inhibition of ferroptosis protects ovarian tissues from damage caused by cisplatin, and for the first time, we have identified the potential of Fer-1 and Rosi to protect ovarian function in female mice undergoing chemotherapy.

Keywords: Acsl4; Chemotherapy; Ferroptosis; Ovarian damage; Specificity protein 1.

MeSH terms

  • Animals
  • Antineoplastic Agents* / adverse effects
  • Cisplatin*
  • Coenzyme A Ligases / genetics
  • Female
  • Ferroptosis*
  • Iron
  • Mice
  • Ovary* / drug effects
  • Ovary* / pathology

Substances

  • Acsl4 protein, mouse
  • Antineoplastic Agents
  • Cisplatin
  • Coenzyme A Ligases
  • Iron